ACQUISTION OF A 300 MHZ NMR SPECTROMETER

该提案要求提供资金以购买Varian Mercury 300 MHz高分辨率NMR分光计。该仪器将安置在犹他州（UU）大学药物化学系，并将为药学院两个系（药物化学、药剂学和药物化学）的九个主要生物医学研究小组提供服务。这些研究小组包括超过45名研究生和博士后，他们依靠日常使用常规NMR进行有机合成，聚合物表征和小分子天然产物结构测定。该仪器将取代已有15年历史的200 MHz仪器，并将成为唯一可用于常规小分子分析的仪器，以满足位于UU健康科学中心的研究人员的需求。来自医学院的次要用户包括放射学，肿瘤科学，生物化学，生理学和人类遗传学部门。新的300 MHz NMR将由药物化学的教职员工管理，并由首席研究员主持。核磁共振设备主任达雷尔教授。戴维斯，将监督仪器的购买和安装，并将协调仪器的使用，维护和用户培训。

This proposal requests funds to acquire a Varian Mercury 300 MHz high- resolution NMR spectrometer. This instrument will be housed in The Department of Medicinal Chemistry at The University of Utah (UU) and will serve nine primary biomedical research groups in two departments within the College of Pharmacy (Medicinal Chemistry and Pharmaceutics and Pharmaceutical Chemistry). These research groups comprise over 45 graduate students and postdoctoral associates who rely on daily access to routine NMR for their work in organic synthesis, polymer characterization, and small molecule natural products structure determination. This instrument will replace a 15-year old 200 MHz instrument, and will be the only instrument available for routine small molecule analysis to serve the needs of researchers located within the Health Sciences Center at UU. Minor users from the School of Medicine include the Departments of Radiology, Oncological Sciences, Biochemistry, Physiology, and Human Genetics. The new 300 MHz NMR would be managed by faculty and staff in Medicinal Chemistry and chaired by the Principal Investigator. The NMR Facility Director, Professor Darrell R. Davis, will oversee the instrument purchase and installation, and will coordinate the instrument use, maintenance, and user training.